Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MSD Finland (Suomen MSD) is the Finnish subsidiary of the global pharmaceutical company Merck & Co., Inc. (known as MSD outside the United States and Canada). Established in 1968 and headquartered in Espoo, the company commercializes and distributes a wide range of innovative prescription medicines, vaccines, and biologic therapies across Finland. Its primary therapeutic areas of focus include oncology, vaccines, infectious diseases, cardiometabolic diseases, and acute hospital care. MSD Finland is heavily involved in clinical research, conducting dozens of clinical trials annually in collaboration with Finnish healthcare providers and academic institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suomen MSD.